ASBPW

Aspire Biopharma Holdings, Inc. Warrant

36 hedge funds and large institutions have $4.53M invested in Aspire Biopharma Holdings, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
36
Holders Change
Holders Change %
0%
% of All Funds
0.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
1
Closed
5
Calls
$2.11M
Puts
Net Calls
+$2.11M
Net Calls Change
+$14K
Name Holding Trade Value Shares
Change
Shares
Change %
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.69M
LP
2
LMR Partners
United Kingdom
$1.29M +$1.29M +125,000 New
MP
3
Mangrove Partners
Connecticut
$666K +$666K +64,705 New
AC
4
Athos Capital
Hong Kong
$257K +$257K +24,999 New
PC
5
Periscope Capital
Ontario, Canada
$87.9K +$30.1K +489,865 +52%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$83.9K
AA
7
AQR Arbitrage
Connecticut
$53.6K
SCM
8
Saba Capital Management
New York
$40K
LA
9
Linden Advisors
New York
$36.6K
Verition Fund Management
10
Verition Fund Management
Connecticut
$34.6K
WAM
11
Wolverine Asset Management
Illinois
$32.1K
KC
12
Kepos Capital
New York
$28K
Barclays
13
Barclays
United Kingdom
$28K
TCA
14
Taconic Capital Advisors
New York
$24K
SC
15
Sculptor Capital
New York
$20.3K
Balyasny Asset Management
16
Balyasny Asset Management
Illinois
$16K
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$16K
CCM
18
Context Capital Management
California
$14K
SRCM
19
Sage Rock Capital Management
New York
$12.8K
CS
20
Clear Street
New York
$12K +$488 +6,227 +4%
PAMP
21
Polar Asset Management Partners
Ontario, Canada
$11.1K
Nomura Holdings
22
Nomura Holdings
Japan
$11K
HCM
23
Highbridge Capital Management
New York
$11K -$151K
WA
24
Whitebox Advisors
Minnesota
$9.99K
KL
25
KIM LLC
Kansas
$8K